{
  "topic_title": "Medical Device (IoMT) Lifecycle Documentation",
  "category": "Asset Security - Asset Retention",
  "flashcards": [
    {
      "question_text": "According to the FDA guidance on medical device cybersecurity, what is a primary goal of implementing a Secure Product Development Framework (SPDF)?",
      "correct_answer": "To reduce the number and severity of vulnerabilities in products throughout the device lifecycle.",
      "distractors": [
        {
          "text": "To ensure compliance with post-market surveillance regulations only.",
          "misconception": "Targets [scope confusion]: Focuses only on post-market, ignoring the full lifecycle."
        },
        {
          "text": "To solely address hardware security vulnerabilities in medical devices.",
          "misconception": "Targets [domain limitation]: Limits SPDF to hardware, excluding software and firmware."
        },
        {
          "text": "To guarantee that no cybersecurity threats can ever impact the device.",
          "misconception": "Targets [unrealistic expectation]: Implies absolute security, which is unattainable."
        }
      ],
      "detailed_explanation": {
        "core_logic": "An SPDF is a set of processes designed to systematically reduce vulnerabilities across a product's entire lifecycle, from design to decommissioning, because this proactive approach is crucial for ensuring ongoing safety and effectiveness.",
        "distractor_analysis": "The distractors incorrectly narrow the scope to post-market, hardware-only, or absolute security, missing the SPDF's holistic, lifecycle-wide vulnerability reduction goal.",
        "analogy": "An SPDF is like building a house with robust, integrated security features from the foundation up, rather than just adding locks after it's built."
      },
      "code_snippets": [],
      "difficulty": "foundational",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "SPDF_BASICS"
      ]
    },
    {
      "question_text": "What is the primary purpose of a Software Bill of Materials (SBOM) in the context of medical device lifecycle documentation, as recommended by the FDA and IMDRF?",
      "correct_answer": "To provide a formal inventory of all software components and their dependencies, aiding in vulnerability management and transparency.",
      "distractors": [
        {
          "text": "To document the source code for all proprietary software used in the device.",
          "misconception": "Targets [scope misunderstanding]: SBOMs list components, not necessarily full source code."
        },
        {
          "text": "To certify that all software components meet specific performance standards.",
          "misconception": "Targets [purpose confusion]: SBOMs focus on inventory and transparency, not certification."
        },
        {
          "text": "To provide a detailed user manual for the device's software functions.",
          "misconception": "Targets [document type confusion]: SBOM is an inventory, not a user guide."
        }
      ],
      "detailed_explanation": {
        "core_logic": "An SBOM lists all software components, including third-party and open-source, because this transparency is essential for identifying potential vulnerabilities and managing supply chain risks throughout the device's lifecycle.",
        "distractor_analysis": "Distractors misrepresent SBOMs as source code repositories, certification tools, or user manuals, failing to grasp their core function as a software inventory for risk management.",
        "analogy": "An SBOM is like an ingredient list for a complex recipe, detailing every component to understand potential allergens or quality issues."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "SBOM_BASICS",
        "CYBERSECURITY_RISK_MANAGEMENT"
      ]
    },
    {
      "question_text": "According to NIST's IoT Cybersecurity Capabilities Catalog, what is a key aspect of 'Device Identification' for manufacturers?",
      "correct_answer": "Establishing communications that describe how to establish unique identification for each IoT device associated with the system.",
      "distractors": [
        {
          "text": "Ensuring the device's firmware is always up-to-date with the latest patches.",
          "misconception": "Targets [related but distinct capability]: Firmware updates are a separate capability, not core to initial identification."
        },
        {
          "text": "Implementing multi-factor authentication for all device access.",
          "misconception": "Targets [misapplication of security control]: MFA is an access control, not an identification method."
        },
        {
          "text": "Providing a detailed user manual for device configuration.",
          "misconception": "Targets [documentation type confusion]: Manuals describe use, not unique device identification."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Unique device identification is foundational for asset management and security oversight, because it allows for precise tracking, auditing, and targeted security measures throughout the device's lifecycle.",
        "distractor_analysis": "Distractors confuse device identification with firmware updates, authentication methods, or user manuals, failing to recognize its role in asset tracking and management.",
        "analogy": "Device identification is like assigning a unique serial number to each product, making it traceable and manageable within a larger inventory."
      },
      "code_snippets": [],
      "difficulty": "foundational",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "IOT_DEVICE_IDENTIFICATION"
      ]
    },
    {
      "question_text": "In the context of medical device cybersecurity, what is the distinction between 'Authentication' and 'Authorization' as described by FDA and IMDRF?",
      "correct_answer": "Authentication verifies identity, while Authorization grants specific privileges or permissions to access resources.",
      "distractors": [
        {
          "text": "Authentication ensures data integrity, while Authorization ensures data confidentiality.",
          "misconception": "Targets [purpose confusion]: Swaps the primary functions of authentication and authorization with integrity and confidentiality."
        },
        {
          "text": "Authentication is a one-way process, while Authorization is a two-way handshake.",
          "misconception": "Targets [process misunderstanding]: Both can involve complex processes, but this distinction is inaccurate."
        },
        {
          "text": "Authentication is used for software, while Authorization is used for hardware access.",
          "misconception": "Targets [component limitation]: Both apply to software and hardware components."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Authentication confirms 'who you are' (identity), often via credentials, while Authorization determines 'what you can do' (permissions) based on that verified identity, because this separation of concerns is critical for secure access control.",
        "distractor_analysis": "Distractors incorrectly assign integrity/confidentiality to authentication/authorization, mischaracterize their processes, or limit their application to specific device components.",
        "analogy": "Authentication is showing your ID to enter a building; Authorization is getting a key card that only opens specific doors within that building."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "comparison",
      "bloom_level": "analyze",
      "prerequisites": [
        "ACCESS_CONTROL_BASICS"
      ]
    },
    {
      "question_text": "According to the FDA guidance, when is a medical device considered a 'cyber device' requiring specific cybersecurity documentation in premarket submissions?",
      "correct_answer": "When it includes validated software, can connect to the internet, and has technological characteristics vulnerable to cybersecurity threats.",
      "distractors": [
        {
          "text": "Only when the device is directly connected to a hospital's internal network.",
          "misconception": "Targets [connectivity limitation]: 'Connect to the internet' is broader than just internal hospital networks."
        },
        {
          "text": "When it utilizes any form of wireless communication, regardless of internet access.",
          "misconception": "Targets [overly broad definition]: Internet connectivity is a key criterion, not just any wireless communication."
        },
        {
          "text": "If the device has any software component, regardless of its connectivity or vulnerability.",
          "misconception": "Targets [missing criteria]: Requires internet connectivity and vulnerability, not just software presence."
        }
      ],
      "detailed_explanation": {
        "core_logic": "A cyber device is defined by three criteria: validated software, internet connectivity, and inherent technological vulnerabilities, because these factors collectively indicate a potential risk surface that requires specific regulatory attention.",
        "distractor_analysis": "Distractors misinterpret 'internet connectivity' narrowly, broaden it incorrectly, or omit the crucial vulnerability and connectivity requirements, failing to capture the full definition.",
        "analogy": "A 'cyber device' is like a smart home appliance that's connected to the internet and has software that could potentially be exploited, not just any electronic device."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "CYBER_DEVICE_DEFINITION"
      ]
    },
    {
      "question_text": "Which of the following BEST describes the 'Total Product Lifecycle' (TPLC) approach to medical device cybersecurity, as emphasized by IMDRF and FDA?",
      "correct_answer": "Considering and managing cybersecurity risks throughout all phases of a device's existence, from conception to end-of-support.",
      "distractors": [
        {
          "text": "Focusing cybersecurity efforts primarily on the manufacturing and testing phases.",
          "misconception": "Targets [incomplete lifecycle]: Ignores crucial pre-market design and post-market phases."
        },
        {
          "text": "Ensuring cybersecurity only until the device is sold to the end-user.",
          "misconception": "Targets [limited scope]: TPLC extends beyond the point of sale to include ongoing use and support."
        },
        {
          "text": "Addressing cybersecurity only when a vulnerability is discovered after market release.",
          "misconception": "Targets [reactive approach]: TPLC emphasizes proactive management throughout, not just reactive fixes."
        }
      ],
      "detailed_explanation": {
        "core_logic": "The TPLC approach mandates that cybersecurity is not a one-time fix but an ongoing process, because threats evolve and devices change, requiring continuous risk assessment and mitigation from initial design through decommissioning.",
        "distractor_analysis": "Distractors incorrectly limit TPLC to specific phases, the point of sale, or reactive measures, failing to grasp its comprehensive, end-to-end nature.",
        "analogy": "TPLC cybersecurity is like maintaining a car throughout its entire life – from the design of its safety features to regular servicing and eventual disposal – not just checking the brakes once."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "TPLC_BASICS",
        "CYBERSECURITY_RISK_MANAGEMENT"
      ]
    },
    {
      "question_text": "In the context of medical device cybersecurity, what is the primary risk associated with 'Legacy Medical Devices' as defined by IMDRF?",
      "correct_answer": "They cannot be reasonably protected against current cybersecurity threats, posing a risk to patient safety and healthcare networks.",
      "distractors": [
        {
          "text": "They are always outdated and inefficient, leading to poor clinical performance.",
          "misconception": "Targets [performance vs. security confusion]: Legacy status is about security, not necessarily performance."
        },
        {
          "text": "They are too expensive to maintain, leading manufacturers to abandon them.",
          "misconception": "Targets [economic vs. security driver]: While cost can be a factor, the primary driver is security risk."
        },
        {
          "text": "They are only a concern for older healthcare facilities with outdated IT infrastructure.",
          "misconception": "Targets [limited applicability]: Legacy devices pose risks regardless of facility age."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Legacy medical devices are defined by their inability to be reasonably secured against current threats, because this inability directly compromises patient safety and the integrity of connected healthcare systems.",
        "distractor_analysis": "Distractors incorrectly link legacy status to performance, cost, or facility age, missing the core definition tied to an inability to be reasonably protected against current cybersecurity threats.",
        "analogy": "A legacy medical device is like an old flip phone in a world of smartphones – it might still make calls, but it can't run modern security apps and is vulnerable to current digital threats."
      },
      "code_snippets": [],
      "difficulty": "advanced",
      "question_type": "definition",
      "bloom_level": "analyze",
      "prerequisites": [
        "LEGACY_DEVICE_DEFINITION",
        "CYBERSECURITY_RISK_ASSESSMENT"
      ]
    },
    {
      "question_text": "According to the FDA's guidance on cybersecurity for medical devices, what is the role of '005_Threat Modeling' in the security risk management process?",
      "correct_answer": "To identify security objectives, risks, and vulnerabilities across the medical device system and define countermeasures.",
      "distractors": [
        {
          "text": "To perform penetration testing on the device to find exploits.",
          "misconception": "Targets [process confusion]: Threat modeling informs testing, but is not testing itself."
        },
        {
          "text": "To document all software components used in the device for compliance.",
          "misconception": "Targets [documentation type confusion]: This describes an SBOM, not threat modeling."
        },
        {
          "text": "To develop the final security architecture of the device.",
          "misconception": "Targets [output vs. input confusion]: Threat modeling is an input to architecture design, not the final output."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Threat modeling is a foundational process that proactively identifies potential security weaknesses and attack vectors, because this understanding is essential for designing effective countermeasures and informing the overall security architecture.",
        "distractor_analysis": "Distractors confuse threat modeling with penetration testing, SBOM documentation, or final architecture design, failing to recognize its role as an early-stage risk identification and planning activity.",
        "analogy": "Threat modeling is like a security architect sketching out potential weak points in a building's design (e.g., poorly lit areas, accessible windows) before construction begins."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "procedure",
      "bloom_level": "apply",
      "prerequisites": [
        "THREAT_MODELING_BASICS",
        "CYBERSECURITY_RISK_MANAGEMENT"
      ]
    },
    {
      "question_text": "Which of the following is a key principle of 'Information Sharing' in medical device cybersecurity, as advocated by IMDRF?",
      "correct_answer": "Information should be shared freely and in good faith to improve patient safety, irrespective of commercial interests.",
      "distractors": [
        {
          "text": "Information should only be shared with regulators to ensure compliance.",
          "misconception": "Targets [limited audience]: Information sharing should be broader, including users and other stakeholders."
        },
        {
          "text": "Manufacturers should share detailed technical specifications to prove product security.",
          "misconception": "Targets [information type confusion]: Sharing focuses on vulnerabilities and risks, not proprietary specs."
        },
        {
          "text": "Information sharing should be delayed until a vulnerability is actively exploited.",
          "misconception": "Targets [reactive vs. proactive approach]: Sharing should be proactive to prevent exploitation."
        }
      ],
      "detailed_explanation": {
        "core_logic": "The principle of sharing information freely and in good faith is crucial because transparency about vulnerabilities and threats allows all stakeholders to better protect patients and improve overall device security, thereby fostering a collaborative ecosystem.",
        "distractor_analysis": "Distractors incorrectly limit information sharing to regulators, focus on proprietary technical details, or advocate for a reactive, post-exploitation approach, missing the core principle of proactive, broad transparency for safety.",
        "analogy": "Information sharing in cybersecurity is like a neighborhood watch program – sharing information about suspicious activity helps everyone stay safer, not just the police."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "INFO_SHARING_PRINCIPLES"
      ]
    },
    {
      "question_text": "Consider a scenario where a medical device manufacturer is developing a new connected insulin pump. According to FDA and IMDRF guidance, which of the following is a critical pre-market cybersecurity consideration?",
      "correct_answer": "Designing secure communication protocols to protect data transfer between the pump, the user's mobile app, and the cloud service.",
      "distractors": [
        {
          "text": "Ensuring the device has a visually appealing user interface for patients.",
          "misconception": "Targets [usability vs. security confusion]: UI design is important but secondary to core security for connected devices."
        },
        {
          "text": "Including a comprehensive warranty that covers all potential cyber incidents.",
          "misconception": "Targets [financial vs. technical solution]: Warranty is a financial/legal aspect, not a technical security design feature."
        },
        {
          "text": "Limiting the device's functionality to prevent any possibility of misuse.",
          "misconception": "Targets [overly restrictive design]: While some restrictions are needed, limiting functionality excessively can impair clinical utility."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Secure communication protocols are paramount for connected medical devices like insulin pumps because they protect sensitive patient data and ensure the integrity of therapeutic commands, thereby preventing harm from data breaches or manipulation.",
        "distractor_analysis": "Distractors focus on aesthetics, financial guarantees, or overly restrictive design, missing the critical need for secure data transmission in a connected medical device.",
        "analogy": "For a connected insulin pump, secure communication is like a sealed, tamper-proof delivery system for critical medication instructions, ensuring they arrive accurately and aren't intercepted or altered."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "scenario",
      "bloom_level": "apply",
      "prerequisites": [
        "SECURE_COMMUNICATIONS",
        "IoMT_SECURITY_PRINCIPLES"
      ]
    },
    {
      "question_text": "What is the primary purpose of 'Coordinated Vulnerability Disclosure' (CVD) in the medical device ecosystem, according to IMDRF?",
      "correct_answer": "To establish formalized processes for reporting, assessing, and disclosing vulnerabilities to enable timely mitigation and protect patients.",
      "distractors": [
        {
          "text": "To allow security researchers to publicly disclose vulnerabilities immediately upon discovery.",
          "misconception": "Targets [misunderstanding of 'coordinated']: CVD implies coordination, not immediate public disclosure."
        },
        {
          "text": "To require manufacturers to fix all reported vulnerabilities within 24 hours.",
          "misconception": "Targets [unrealistic timeline]: CVD focuses on a structured process, not an arbitrary, immediate fix deadline."
        },
        {
          "text": "To provide a platform for manufacturers to market their security capabilities.",
          "misconception": "Targets [commercial vs. safety focus]: CVD's primary goal is patient safety, not marketing."
        }
      ],
      "detailed_explanation": {
        "core_logic": "CVD is essential because it provides a structured, collaborative approach for identifying and addressing security flaws before they can be exploited, thereby enhancing transparency and protecting patient safety through timely communication and remediation.",
        "distractor_analysis": "Distractors misrepresent CVD as immediate disclosure, an unrealistic fix timeline, or a marketing tool, failing to capture its core function of coordinated, risk-based vulnerability management.",
        "analogy": "CVD is like a building inspector reporting a potential safety hazard to the owner, who then works to fix it before it causes harm, and then informs residents about the issue and the fix."
      },
      "code_snippets": [],
      "difficulty": "advanced",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "CVD_BASICS",
        "VULNERABILITY_MANAGEMENT"
      ]
    },
    {
      "question_text": "When discussing 'Cybersecurity Risk Assessment' for medical devices, what is the key difference in approach compared to traditional 'Safety 002_Risk Management' (e.g., ISO 14971), as noted by the FDA?",
      "correct_answer": "Cybersecurity risk assessment focuses on exploitability and potential patient harm from malicious actors, whereas safety risk management often focuses on physical injury or device malfunction.",
      "distractors": [
        {
          "text": "Safety risk management uses probabilistic analysis, while cybersecurity risk assessment is purely qualitative.",
          "misconception": "Targets [oversimplification of methods]: Both can involve qualitative and quantitative elements, but the core focus differs."
        },
        {
          "text": "Cybersecurity risk assessment is only performed post-market, while safety risk management is pre-market.",
          "misconception": "Targets [timing error]: Both risk assessments should ideally occur throughout the TPLC."
        },
        {
          "text": "Safety risk management considers hardware failures, while cybersecurity risk assessment only considers software vulnerabilities.",
          "misconception": "Targets [component limitation]: Both safety and cybersecurity can involve hardware and software."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Cybersecurity risk assessment specifically evaluates the potential for intentional exploitation of vulnerabilities to cause patient harm, a focus distinct from safety risk management's broader scope of physical harm or malfunction, because the threat landscape and attack vectors are unique.",
        "distractor_analysis": "Distractors misrepresent the methodologies, timing, or scope of these risk assessments, failing to distinguish the focus on intentional exploitation and patient harm in cybersecurity.",
        "analogy": "Safety risk assessment is like checking for trip hazards on a staircase; cybersecurity risk assessment is like checking for a burglar's potential entry points into a house."
      },
      "code_snippets": [],
      "difficulty": "expert",
      "question_type": "comparison",
      "bloom_level": "analyze",
      "prerequisites": [
        "RISK_MANAGEMENT_PRINCIPLES",
        "CYBERSECURITY_RISK_ASSESSMENT"
      ]
    },
    {
      "question_text": "According to NIST's IoT Cybersecurity Capabilities Catalog, what is the purpose of 'Device Security' capabilities from a manufacturer's perspective?",
      "correct_answer": "To establish communications detailing the security capabilities of the IoT device's software and hardware components.",
      "distractors": [
        {
          "text": "To provide remote access for manufacturers to perform device maintenance.",
          "misconception": "Targets [access control vs. capability description]: Remote access is a function, not the description of security capabilities."
        },
        {
          "text": "To implement automatic firmware updates without user intervention.",
          "misconception": "Targets [specific feature vs. general capability]: Automatic updates are one possible security feature, not the sole purpose."
        },
        {
          "text": "To ensure the device is compliant with all international cybersecurity standards.",
          "misconception": "Targets [absolute compliance claim]: Manufacturers describe capabilities, not guarantee universal compliance."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Manufacturers must detail the security capabilities of their IoT device's software and hardware because this documentation enables customers to understand and configure the device securely, thereby managing risks effectively.",
        "distractor_analysis": "Distractors confuse describing security capabilities with enabling remote access, mandating automatic updates, or guaranteeing universal compliance, missing the core purpose of transparent documentation.",
        "analogy": "Describing 'Device Security' capabilities is like a car manufacturer providing a manual that explains the safety features (airbags, ABS) and how they work, so the driver can use them effectively."
      },
      "code_snippets": [],
      "difficulty": "foundational",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "IOT_DEVICE_SECURITY_CAPABILITIES"
      ]
    },
    {
      "question_text": "In the context of medical device lifecycle documentation, what is the significance of 'End of Support' (EOS) and 'End of Life' (EOL) dates for manufacturers, as per IMDRF guidance?",
      "correct_answer": "These dates signify when a manufacturer ceases comprehensive cybersecurity support, transferring residual risk responsibility to the customer.",
      "distractors": [
        {
          "text": "They indicate when the device's warranty expires, not its security support.",
          "misconception": "Targets [warranty vs. security lifecycle confusion]: EOS/EOL relate to security support, not just warranty."
        },
        {
          "text": "They are marketing terms used to encourage customers to purchase newer models.",
          "misconception": "Targets [motivation confusion]: While it can influence purchasing, EOS/EOL are about supportability and risk."
        },
        {
          "text": "They mean the device is immediately obsolete and must be decommissioned by law.",
          "misconception": "Targets [absolute requirement vs. risk transfer]: Decommissioning is recommended, but risk transfer to the customer is the key implication."
        }
      ],
      "detailed_explanation": {
        "core_logic": "EOS and EOL dates are critical because they formally mark the end of a manufacturer's commitment to providing cybersecurity support, thereby clarifying the point at which the responsibility for managing residual risks shifts to the device user or healthcare provider.",
        "distractor_analysis": "Distractors misinterpret EOS/EOL as solely warranty-related, marketing tactics, or immediate legal mandates for decommissioning, failing to recognize their significance in risk transfer and support lifecycle.",
        "analogy": "EOS/EOL dates for a medical device are like a software company announcing they will no longer provide updates or support for an old operating system; users must then manage the risks of using unsupported software."
      },
      "code_snippets": [],
      "difficulty": "advanced",
      "question_type": "definition",
      "bloom_level": "analyze",
      "prerequisites": [
        "DEVICE_LIFECYCLE_MANAGEMENT",
        "CYBERSECURITY_SUPPORT_POLICY"
      ]
    },
    {
      "question_text": "Consider a scenario where a healthcare provider is integrating a new IoMT device into their network. According to NIST guidance on manufacturer documentation, what information is crucial for the provider to assess the device's cybersecurity risk?",
      "correct_answer": "Details about the device's security capabilities, how to configure and use them, and any assumptions made during development about its use.",
      "distractors": [
        {
          "text": "The manufacturer's marketing materials highlighting the device's advanced features.",
          "misconception": "Targets [marketing vs. technical information]: Marketing focuses on benefits, not detailed security risk assessment data."
        },
        {
          "text": "A list of all third-party software components used, without explanation of their security implications.",
          "misconception": "Targets [incomplete information]: An SBOM alone is insufficient; context on security implications is needed."
        },
        {
          "text": "The device's original design schematics and source code.",
          "misconception": "Targets [proprietary information vs. usable documentation]: Full schematics/code are usually proprietary and not provided for risk assessment."
        }
      ],
      "detailed_explanation": {
        "core_logic": "Understanding the device's security capabilities, configuration, and the manufacturer's development assumptions is vital because it allows healthcare providers to properly implement controls, assess residual risks, and ensure the device integrates safely into their environment.",
        "distractor_analysis": "Distractors focus on marketing hype, incomplete technical data, or proprietary information, failing to identify the practical, actionable security documentation needed for risk assessment.",
        "analogy": "When buying a new appliance, you need the manual explaining its safety features and how to use them correctly, not just the glossy brochure or the internal wiring diagram."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "scenario",
      "bloom_level": "apply",
      "prerequisites": [
        "MANUFACTURER_DOCUMENTATION",
        "CYBERSECURITY_RISK_ASSESSMENT"
      ]
    },
    {
      "question_text": "What is the primary function of 'Compensating Risk Control Measures' (CRCMs) in medical device cybersecurity, as discussed in IMDRF and FDA guidance?",
      "correct_answer": "To provide security protections when a device's inherent design cannot fully mitigate a vulnerability, often implemented by the user or healthcare provider.",
      "distractors": [
        {
          "text": "To replace all security features of a device that are found to be defective.",
          "misconception": "Targets [replacement vs. mitigation]: CRCMs supplement or mitigate, not necessarily replace all features."
        },
        {
          "text": "To be implemented by the manufacturer during the initial design phase.",
          "misconception": "Targets [implementation timing]: CRCMs are often applied post-design or when inherent controls are insufficient."
        },
        {
          "text": "To guarantee that a device is completely immune to all future cyber threats.",
          "misconception": "Targets [unrealistic guarantee]: CRCMs reduce risk, they don't eliminate all future threats."
        }
      ],
      "detailed_explanation": {
        "core_logic": "CRCMs are crucial because they offer a practical way to manage residual risks when a device's design limitations prevent full vulnerability mitigation, thereby extending the device's usable life and protecting patient safety through external controls.",
        "distractor_analysis": "Distractors misrepresent CRCMs as replacements, pre-design implementations, or guarantees of absolute security, failing to capture their role as supplementary risk mitigation tools.",
        "analogy": "If your house's main door lock is weak (inherent control), a compensating control might be adding a security bar or reinforcing the door frame, rather than replacing the entire door."
      },
      "code_snippets": [],
      "difficulty": "intermediate",
      "question_type": "definition",
      "bloom_level": "understand",
      "prerequisites": [
        "COMPENSATING_CONTROLS",
        "RISK_MITIGATION"
      ]
    }
  ],
  "generation_metadata": {
    "model": "google/gemini-2.5-flash-lite",
    "num_generated": 16,
    "temperature": 0.1,
    "web_citations": [],
    "research_method": "openrouter_web_plugin",
    "search_query": "Medical Device (IoMT) Lifecycle Documentation Asset Security best practices",
    "latency_ms": 23790.996
  },
  "timestamp": "2026-01-01T16:16:54.574707"
}